Stockreport

Metacrine Reports Third-Quarter 2021 Results

Metacrine, Inc.  (MTCR) 
PDF SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients [Read more]